Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 9076 AL 9090

Self-care and its assessment in the patient-caregiver dyad in Parkinson's disease: a mixed-method study protocol

Petralito M, Tedesco C, Isaias IU, Muttillo G, Castaldo A, Pucciarelli G, Caruso R.

BMJ Open. 2025 Nov 4;15(11):e107471. doi: 10.1136/bmjopen-2025-107471.

Glucocerebrosidase Target Engagement and Therapeutic Plasma and Cerebrospinal Fluid Levels After GT-02287 Administration in Healthy Volunteers

Pozzi R, De Sciscio M, Bosetti M, Cano-Crespo S, Taylor J, Ignoni T, Hannestad J.

Mov Disord. 2026 Feb;41(2):522-527. doi: 10.1002/mds.70111. Epub 2025 Nov 5.

Validation of the Psychosis and Hallucinations Questionnaire in Lewy Body Dementia

Gunawardana CW, Burke PGR, Matar E, Lewis SJG.

J Geriatr Psychiatry Neurol. 2026 Jul;39(4):368-379. doi: 10.1177/08919887251395314. Epub 2025 Nov 7.

Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson's disease: the ADepT-PD RCT pilot

Schrag A, Carroll C, Lewis G, Serfaty M, Duncan G, Molloy S, Whipps J, McLennan B, Weng JYJ, Hunter RM, Clarke CS, Freemantle N, Embleton-Thirsk A.

Health Technol Assess. 2025 Nov;29(57):1-78. doi: 10.3310/HFDO7575.

Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study

Wilkens I, Bebermeier S, Heine J, Ruf VC, Compta Y, Molina Porcel L, Troakes C, Vamanu A, Downes S, Irwin DJ, Cohen J, Lee EB, Nilsson CF, Englund EM, Nemati M, Katzdobler S, Levin J, Bernhardt AM, Pantelyat A, Seemiller J, Berger S, Van Swieten JC, Dopper EGP, Rozemuller AJM, Kovacs GG, Bendahan N, Lang AE, Herms J, Höglinger GU, Hopfner F.

Neurology. 2025 Dec 9;105(11):e214316. doi: 10.1212/WNL.0000000000214316. Epub 2025 Nov 13.

Can wearable sensor based measures of gait accurately reflect Parkinson's disease severity? A systematic review and meta-analysis

Youssef H, Sabıroğlu M, Mahmoud Abdel-Rahman S, Hasanin T, Manay M, Gönül MN, Mancini M, Del Din S, Vural A.

Parkinsonism Relat Disord. 2026 Jan;142:108108. doi: 10.1016/j.parkreldis.2025.108108. Epub 2025 Nov 8.

Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants

Pokorny R, Ryan JM, Abd-Elaziz K, van den Berg F, Rabiner E, Searle GE, Schneider M, Wiessner C, Stallaert JF, Permanne B, Quattropani A, Beher D.

Mov Disord. 2026 Feb;41(2):436-444. doi: 10.1002/mds.70104. Epub 2025 Nov 15.

GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility

Parlar SC, Lee Y, Gan-Or Z.

Mov Disord. 2026 Mar;41(3):761-766. doi: 10.1002/mds.70127. Epub 2025 Nov 15.

Zolpidem in Parkinson's disease: An unexpected friend?

Mittal SO, Girigosavi KB.

Parkinsonism Relat Disord. 2026 Jan;142:108113. doi: 10.1016/j.parkreldis.2025.108113. Epub 2025 Nov 12.

Phenoconsonance: A New Form of Neurological Analysis That Complements Anatomical Localization and Disease Pattern Recognition

Guell X, Schmahmann JD.

J Neuropsychiatry Clin Neurosci. 2026 Spring;38(2):107-119. doi: 10.1176/appi.neuropsych.20250067. Epub 2025 Nov 17.

CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression

Coughlin DG, Jain L, Khrestian M, Bozoki AC, Galvin JE, Irwin DJ, Lippa CF, Litvan I, Pillai JA, Tousi B, Lopez OL, Berman S, Tsuang DW, Zabetian CP, Fleisher JE, Taylor AS, Leverenz JB, Bekris LM, Galasko D; Dementia With Lewy Bodies Consortium.

Neurology. 2025 Dec 23;105(12):e214346. doi: 10.1212/WNL.0000000000214346. Epub 2025 Nov 17.

Treatment-Emergent Parkinsonism in Four Patients Treated with Chimeric Antigen Receptor T-Cell Therapy

Sanderson JB, Lin YH, Su K, Wang Y, Portuguese A, Gauthier J, Durbin M, Banerjee R.

Mov Disord Clin Pract. 2025 Nov 19. doi: 10.1002/mdc3.70452. Online ahead of print.

[Parkinson's Disease and Pregnancy. Resolution of The National Society for the Study of Parkinson's Disease and Movement Disorders]

Bril EV, Turgunkhujaev OE, Dudchenko NG, Gamaleya AA, Zhukova NG, Zalyalova ZA, Zimnyakova OS, Illarioshkin SN, Katunina EA, Kulua TK, Levin OS, Litvinenko IV, Smolenceva IG, Timofeeva AA, Tomskiy AA, Fedorova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(11. Vyp. 2):55-60. doi: 10.17116/jnevro202512511255.

Towards effective interventions: scoping review on prevention and modifiable risk factors of neurodegenerative diseases

Veloso-Luis A, Diaconu S, Mendes M, Ferreira JJ.

Neurol Sci. 2025 Dec;46(12):6193-6215. doi: 10.1007/s10072-025-08452-9. Epub 2025 Nov 21.

Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial

Cilia R, Cham M, Obese V, Akpalu A, Cereda E, Ame-Bruce E, Laryea R, Caronni S, Sarfo FS, Sorbo FD, Fahn S, Pezzoli G.

J Parkinsons Dis. 2026 Feb;16(1):99-109. doi: 10.1177/1877718X251383721. Epub 2025 Nov 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias